Pharmacologic therapy for inflammatory bowel disease refractory to steroids.
Although corticosteroids are an effective treatment for induction of remission in inflammatory bowel disease (IBD), many patients are dependent on or refractory to corticosteroids. This review is based on scrutinizing current literature with emphasis on randomized controlled trials, meta-analyses, and Cochrane reviews on the management of IBD refractory to corticosteroids. Based on this evidence, we propose algorithms and optimization strategies for use of immunomodulator and biologic therapy in IBD refractory to corticosteroids.
['Martínez-Montiel|M P|MP|', 'Casis-Herce|B|B|', 'Gómez-Gómez|G J|GJ|', 'Masedo-González|A|A|', 'Yela-San Bernardino|C|C|', 'Piedracoba|C|C|', 'Castellano-Tortajada|G|G|']
immunomodulators Crohn’s disease anti-tumor necrosis factor alpha drug levels treatment optimization ulcerative colitis